IMMUVision

IMMUVision

IMMUVision

Our path to the goal

IMMUVision is a new research and care project by the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP aimed at improving treatment for patients with complex immune and inflammatory diseases.

 

Aim of the project

The project aims to develop standardized documentation and promote interdisciplinary exchange in inflammatory medicine. It not only contributes to optimizing the quality of care, but also provides new insights into the diagnosis and treatment of immune diseases that affect multiple organ systems, thereby improving the long-term care of these patients.

© videoflow- Freepik.com

Aim of the project

Development of a digital platform that bundles data on diagnoses, disease progression, and therapies and compares it with study and guideline data to support therapy decisions.

 

Further links:

Fraunhofer ITMP 

Fraunhofer IGD

Mehr Info

News

Here you will find all press releases and other news items, as well as all events related to the IMMUVision project.

News / 15.1.2026

Fraunhofer ITMP develops "IMMUVision", a digital twin for complex immune disorders

The Fraunhofer Institute for Translational Medicine and Pharmacology ITMP is officially launching the IMMUVision project today with a kick-off event.

More information

News / 18.12.2025

Fraunhofer ITMP: Digital innovation leads to "Highest Customer Acquisition of the Month" in October

Fraunhofer ITMP has received a €3.28 million contract from Lilly Deutschland GmbH for the "Immuvision" project led by Priv.-Doz. Dr. Michaela Köhm and Dr. Tanja Roßmanith. The aim is to develop a digital platform for patients with immune-mediated inflammatory systemic diseases, with technical support from Fraunhofer IGD.

To the article

Further information about the project

project managers

Contact Press / Media

Dr. Michaela Köhm

Head of Innovation Area 4D Clinic

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Sandhöfer Allee 1
60528 Frankfurt am Main, Germany

Phone +49 69 269525-274

Contact Press / Media

Dr. Tanja Roßmanith

Head of Innovation Area Proof-of-Concept & Clinical Studies

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Sandhöfer Allee 1
60528 Frankfurt am Main, Germany

Phone +49 69 269 525-317

project partners

Fraunhofer ITMP

Project manager; conducts research and development work; contributes expertise in the research and management of immune diseases and evidence-based therapy optimization.

 

Fraunhofer IGD

Conducts software development for user dashboards and data analysis. Contributes leading expertise in visual data analytics, user experience design, and medical image processing.

 

Lilly Deutschland GmbH

Supports development and distribution in order to gain insights for its own research purposes, accelerate market availability, and improve patient access to innovative care offerings.